Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
40.07
-0.16 (-0.40%)
At close: Oct 9, 2026, 4:00 PM EDT
40.24
+0.17 (0.42%)
After-hours: Oct 9, 2026, 7:52 PM EDT
Sanofi Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 12,300 | 11,244 | 12,205 | 13,170 | 10,735 | 10,606 | - | 14,157 | - | 11,118 | - | 12,698 | 10,588 | 10,863 | 11,456 | 13,138 | 10,742 | 10,053 | 10,415 | 10,829 |
Revenue Growth | 14.58% | 6.02% | - | -6.97% | - | -4.61% | - | 11.49% | - | 2.35% | - | -3.35% | -1.43% | 8.06% | 9.99% | 21.32% | 18.76% | 13.13% | 6.97% | 9.62% |
Gross Profit Gross Profit Growth | 9,411 | 8,188 | 8,575 | 9,758 | 7,743 | 7,717 | - | 10,072 | - | 7,679 | - | 8,857 | 7,325 | 7,784 | 7,725 | 9,307 | 7,495 | 7,173 | 6,943 | 7,591 |
Operating Income Operating Income Growth | 2,587 | 2,249 | 1,740 | 3,784 | 1,712 | 2,424 | - | 4,079 | - | 2,032 | - | 3,477 | 1,546 | 2,821 | 1,661 | 4,652 | 1,841 | 2,573 | 1,240 | 3,203 |
Net Income Net Income Growth | 343 | 1,614 | -801 | 2,802 | 3,940 | 1,872 | - | 2,815 | - | 1,133 | - | 2,525 | 1,435 | 1,995 | 3,111 | 2,076 | 1,175 | 2,009 | 1,130 | 2,317 |
Earnings Per Share EPS Growth | 0.28 | 1.34 | -0.66 | 2.30 | 3.23 | 1.52 | - | 2.25 | - | 0.91 | - | 2.01 | 1.14 | 1.60 | 2.48 | 1.66 | 0.94 | 1.61 | 0.90 | 1.85 |
EPS Growth | -91.20% | -11.66% | - | 2.39% | - | 67.22% | - | 11.50% | - | -43.19% | - | 21.66% | 21.70% | -0.70% | 175.50% | -10.33% | -0.91% | 28.30% | 6.52% | 18.81% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Dupixent Dupixent Growth | 5,154 | 4,170 | 4,246 | 4,156 | 3,832 | 3,480 | 3,458 | 3,476 | 3,303 | 2,835 | 2,990 | 2,847 | 2,562 | 2,316 | 2,402 | 2,314 | 1,963 | 1,614 | 1,549 | 1,410 |
Pharma Pharma Growth | 10,448 | 9,216 | 9,264 | 9,077 | 8,781 | 8,568 | 8,388 | 8,355 | 8,297 | 7,762 | - | - | - | - | - | - | - | - | - | - |
Total Vaccine Total Vaccine Growth | 1,149 | 1,293 | 2,039 | 3,357 | 1,213 | 1,327 | 2,176 | 3,802 | 1,142 | 1,177 | 1,986 | 3,098 | 1,223 | 1,167 | 1,716 | 3,315 | 1,178 | 1,020 | 1,964 | 2,422 |
Revenue (Total) Revenue (Total) Growth | 12,300 | 11,244 | 12,205 | 13,170 | 10,735 | 10,606 | 11,420 | 12,977 | 11,380 | 9,726 | 12,201 | 11,540 | 10,682 | 9,470 | 11,456 | 13,138 | 10,742 | 10,053 | 10,415 | 10,829 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 6,350 | 5,544 | 7,674 | 8,906 | 15,359 | 7,991 | 7,556 | 6,795 | 6,795 | 8,710 | 8,822 | 7,993 | 7,993 | 12,736 | 12,736 | 6,899 | 6,899 | 10,109 | 10,109 | 9,722 |
Total Debt Total Debt Growth | 23,576 | 20,021 | 20,410 | 21,755 | 22,285 | 21,047 | 17,913 | 23,751 | 23,751 | 18,423 | 18,423 | 21,027 | 21,027 | 21,212 | 21,212 | 21,237 | 21,237 | 22,415 | 22,415 | 21,649 |
Net Cash (Debt) Net Cash Growth | -17,226 | -14,477 | -12,736 | -12,849 | -6,926 | -13,056 | -10,357 | -16,956 | -16,956 | -9,713 | -9,601 | -13,034 | -13,034 | -8,476 | -8,476 | -14,338 | -14,338 | -12,306 | -12,306 | -11,927 |
Net Cash Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -14.40 | -12.02 | -10.50 | -10.55 | -5.69 | -10.58 | - | -13.53 | - | -7.78 | - | -10.40 | -10.42 | -6.78 | -6.76 | -11.44 | -11.46 | -9.85 | -9.81 | -9.51 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,960 | 1,683 | 3,445 | 3,750 | 1,462 | 2,093 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Capital Expenditures CapEx Growth | -882 | - | -1,762 | 845 | -845 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Free Cash Flow Growth | 2,078 | 1,683 | 1,683 | 4,595 | 617 | 2,093 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Growth | 236.79% | -19.59% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Gross Margin | 76.51% | 72.82% | 70.26% | 74.09% | 72.13% | 72.76% | - | 71.14% | - | 69.07% | - | 69.75% | 69.18% | 71.66% | 67.43% | 70.84% | 69.77% | 71.35% | 66.66% | 70.10% |
Operating Margin | 21.03% | 20.00% | 14.26% | 28.73% | 15.95% | 22.86% | - | 28.81% | - | 18.28% | - | 27.38% | 14.60% | 25.97% | 14.50% | 35.41% | 17.14% | 25.59% | 11.91% | 29.58% |
Pretax Margin | 6.73% | 17.91% | -9.46% | 26.64% | 13.67% | 20.74% | - | 25.29% | - | 11.78% | - | 24.42% | 16.23% | 22.72% | 35.60% | 20.40% | 12.87% | 23.37% | 13.51% | 27.26% |
Profit Margin | 2.79% | 14.35% | -6.56% | 21.28% | 36.70% | 17.65% | - | 19.88% | - | 10.19% | - | 19.89% | 13.55% | 18.37% | 27.16% | 15.80% | 10.94% | 19.98% | 10.85% | 21.40% |
FCF Margin | 16.89% | 14.97% | 13.79% | 34.89% | 5.75% | 19.73% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | - | - | 4.120 | - | - | - | - | - | - | - | - | - | - | - | 3.560 | - | - | - | 3.330 |
Dividend Per Share Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.91% | - | - | - | - |
Dividend Yield | - | - | 10.38% | - | - | - | - | - | - | - | - | - | - | - | 8.92% | - | - | - | 8.82% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | 22.80 | 13.22 | - | 11.10 | 11.61 | 26.62 | - | 32.67 | - | 22.30 | - | 14.03 | 14.25 | 14.98 | 13.46 | 15.39 | 18.17 | 17.36 | 17.90 | 16.98 |
P/FCF Ratio | 8.99 | 11.65 | 11.20 | 13.08 | 36.96 | 59.61 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
PS Ratio | 1.85 | 2.11 | 2.15 | 2.77 | 2.82 | 5.04 | - | 5.10 | - | 3.30 | - | 2.79 | 2.67 | 2.71 | 2.48 | 2.22 | 2.87 | 2.86 | 2.84 | 2.71 |